Navigation Links
Indevus Pharmaceuticals Announces Retirement Plans For Its CEO and Chairman
Date:3/3/2008

LEXINGTON, Mass., March 3 /PRNewswire-FirstCall/ -- Indevus Pharmaceuticals, Inc. (Nasdaq: IDEV) announced today that Glenn L. Cooper, M.D. plans to retire as Indevus' Chief Executive Officer and Chairman of the Board of Directors later this year on or prior to September 1, 2008.

Dr. Cooper said, "After 15 years at the helm of the company and at the age of 55, I feel the time is right for me to retire from this marvelous company. Over the years, we have successfully developed and commercialized innovative products and have built a specialty pharmaceutical company tightly focused on urology and endocrinology. We have a strong capable senior management team and employee group who has accomplished great things on the clinical, regulatory, business development, legal, manufacturing and commercialization fronts. With five products on the market and two more anticipated product launches later this year, I believe the company is poised for its next phase of success leading to profitability. I regard the anticipated future approval of NEBIDO(R) as a fitting capstone to my tenure at the company and I intend to see the regulatory process through to its conclusion."

Cheryl Morley, presiding director and chairman of Indevus' Nominating and Governance Committee said, "The Board is extremely appreciative of Glenn's long and effective service and we are sorry to see him depart. We intend to recruit an experienced pharmaceutical executive capable of managing a growing and complex commercial company. Glenn has built a talented team of senior executives and we expect that the transition to a new CEO will be seamless."

Indevus and Dr. Cooper have entered into an Executive Retirement Agreement pursuant to which Dr. Cooper shall maintain
'/>"/>

SOURCE Indevus Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Indevus Pharmaceuticals to Present at Upcoming Investor Conferences
2. FDA Accepts New Drug Application for NEBIDO(R) Submitted by Indevus
3. Indevus Pharmaceuticals To Present at RBC Capital Markets Conference
4. Indevus To Announce First Quarter Fiscal 2008 Financial Results On Thursday, February 7, 2008
5. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
6. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
7. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
8. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
9. Vista Partners Updates Coverage on Tapestry Pharmaceuticals
10. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
11. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Tapestry Pharmaceuticals, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/18/2014)... 2014) -- A group of scientists from the ... Sanders-Brown Center on Aging has found interesting new ... function in Parkinson,s disease (PD). , Published ... study, which assessed cognitive function in depressed and ... replacement therapy commonly used to treat motor symptoms ...
(Date:4/18/2014)... your worst memories? How did it make you feel? ... negative personal experience, such as how sad you were ... distress, especially when you can,t stop thinking about it. ... about the context of the memories, rather than how ... to alleviate the negative effects of these memories, a ...
(Date:4/18/2014)... discovery by Northwestern Medicine scientists could lead to potential ... in people with scleroderma. , Fibrosis, or scarring, ... of the skin and lungs can lead to serious ... concept for new therapeutic options centers on findings made ... who identified the role that a specific protein plays ...
(Date:4/17/2014)... the most popular vaccine brands for children may not ... overlooking some cost factors when choosing vaccines, driving the ... according to a new study by University of Illinois ... be driven by numerous factors," says Sheldon H. Jacobson, ... computer science and of mathematics at the U. of ...
(Date:4/17/2014)... MANHASSET, NY In a review published in the ... MD, president of The Feinstein Institute for Medical Research, ... the medical community,s approach to treating sepsis, ... 200,000 Americans. , Sepsis occurs when molecules released into ... inflammation throughout the body. Inflammation is necessary for maintaining ...
Breaking Medicine News(10 mins):Health News:Treating depression in PD patients: New research 2Health News:New study suggests a better way to deal with bad memories 2Health News:New study suggests a better way to deal with bad memories 3Health News:New clues on tissue scarring in scleroderma 2Health News:Study recalculates costs of combination vaccines 2Health News:Feinstein Institute researcher publishes new perspective on sepsis 2
... , , , , ... ) today announced that it will release financial results for its fiscal fourth ... the markets close. Cardica,s management will host a conference call at 4:30 p.m. ... company,s business. , , Conference Call Details , ...
... , , MINNEAPOLIS, July ... leading provider of integrated employee health and productivity management solutions, will conduct ... of 2009, ended June 30, 2009. The call is scheduled for 4:30 ... Participants can dial (800) 860-2442 or (412) 858-4600 to access the conference ...
... , , , ... today announced several key enhancements to its executive management team. The ... company for further profitable expansion. , , Heather ... role, Bresch will take on additional leadership responsibilities related to the ...
... , , PALO ALTO, Calif., July 29 ... Meeting of the Society of NeuroInterventional Surgery ( www.snisonline.org ) ... guiding catheter, the Echo(TM) Distal Access Catheter. , ... the ability to enable endovascular procedures in very far-reaching vessel locations -- ...
... ... leader in LED (light emitting diode) television and motion picture lighting equipment, will be ... Sciences for its proprietary lighting systems. , ... Hollywood, CA (PRWEB) July 29, 2009 -- Litepanels, Inc., the ...
... ... prepare to take the Registered Medical Transcriptionist exam and earn their RMT credential. ... Provo, Utah (PRWEB) ... a new online training program designed to help medical transcriptionists prepare to take the ...
Cached Medicine News:Health News:Cardica to Announce Fiscal 2009 Fourth Quarter and Year End Financial Results on Thursday, August 13, 2009 2Health News:Mylan Announces Enhancements to Executive Management Team 2Health News:Mylan Announces Enhancements to Executive Management Team 3Health News:Nfocus Neuromedical Announces European Approval for Novel Guiding Catheter at Society of NeuroInterventional Surgery 2Health News:Litepanels to Receive First-Ever Emmy Statue for Lighting Equipment Technology 2Health News:Career Step Launches New Exam Prep Course for Medical Transcription Industry Credential 2
(Date:1/15/2014)...  Research and Markets ( http://www.researchandmarkets.com/research/6k27gw/dental ) has announced the ... Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 ... (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) ... in order to treat dental impairments, for tooth restoration ...
(Date:1/15/2014)... Jan. 15, 2014  Celsion Corporation (the "Company") (NASDAQ: ... from institutional investors to purchase an aggregate of approximately ... at-the-market registered direct offering, led by a dedicated health ... purchase agreements with these investors pursuant to which the ...
(Date:1/15/2014)... 2014 BreedIT Corp (OTC: BRDT), through ... of highly sophisticated agro-breeding solutions for plant breeders and ... Company,s board of directors appointed chemistry and pharmaceutical industry ... member of the board. From 1975 to ...
Breaking Medicine Technology:Dental Consumables Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2018 2Dental Consumables Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2018 3Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 2Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 3BreedIT (OTC: BRDT) Appoints Chemistry and Pharmaceutical Industry Expert Dr. Ben-Zion Weiner to Its Board of Directors 2BreedIT (OTC: BRDT) Appoints Chemistry and Pharmaceutical Industry Expert Dr. Ben-Zion Weiner to Its Board of Directors 3
... Academy of Managed Care Pharmacy (AMCP) is pleased to ... Pharmacy Claims – a resource that fulfills a ... challenge between the community and managed care pharmacy practice. ... The 21-page Model Guidelines document ...
... today that it has completed notifying customers of a ... the United States and has confirmed that 51 have ... on October 11, 2011 to address a manufacturing issue ... reports of ventilator malfunctions, failures or injuries related to ...
Cached Medicine Technology:Academy of Managed Care Pharmacy (AMCP) Releases Model Audit Guidelines for Pharmacy Claims 2Academy of Managed Care Pharmacy (AMCP) Releases Model Audit Guidelines for Pharmacy Claims 3Respironics, Inc. Completes Voluntary Recall Notification of a Limited Number of Trilogy 100 Ventilators 2